The name of the seminar is "Preclinical and Phase I clinical trials in the Drug Development Process". The speakers are going to broach a number of up-to-date and topical questions that affect both start-up companies and representatives of big pharmaceutical and biotechnology companies in Russia. The audience will have a chance to listen to the presentations of spokesmen from Russian (represented by OCT) and European (represented by Meditox) pre-clinical centers, phase I units and clinical research centers (Pirogov Russian National Research Medical University).
OCT pre-clinical trials manager, Maria Zaitseva, will make a presentation on a topic of multicenter preclinical trials organization in accordance with the GLP rules and harmonization of regulatory framework. She will also touch upon accreditation of Russian research centers.
Another speaker from OCT side is Vladimir Chistyakov, OCT leading medical writer and expert in clinical trials, who will share his view on the rational approach for the choice of the doses of investigational drugs in first-in-human trials on the example of anti-cancer drugs.
From the BD side, OCT will be represented at the event by Anna Yanaeva, OCT Business Development Manager, who will be eager to discuss how OCT can help you in pre-clinical and clinical program planning and realization.
This is not the first time OCT is organizing events and seminars in joint with Skolkovo. In April, 2014 we had a wonderful experience having conducted a workshop on practical aspects of clinical development programs planning and execution. OCT has received highly positive feedback from the participants of the event.
We are sure this year’s seminar will be even greater experience!
The event is free for participation and will take place on March, 19th in Skolkovo Hypercube.